Abstract:Background Glaucoma is the second leading cause of blindness,which is characterized by processing retinal ganglion cells (RGCs) loss and optic nerve dystrophy.Clinical study showed that lowing IOP can not arrest the glaucomatous damage of RGCs.To seek a neuroprotective drug is an urgent need.Objective This present study focused on the effect of triptolide,a natural biologically active compound extracted from Tripterygium wilfordii,on RGCs in glaucomatous eyes. Methods Glaucoma animal models were established in the right eyes of 80 clean Wistar rats by combination with aspiration of aqueous humor and phtocoagulation on anterior chamber angle.Wistar rats were assigned to two groups at random.Triptolide (5μg/kg) was intraperitoneally injected daily from three days before photocoagulation through scarification of animals (total 8 weeks),and same amount of physiologic saline solution was used at the same way.IOP was measured with a Tonopen XL tonometer at at 1day,3,5,7 days and weekly for 8-week duration after phtocoagulation.RGCs numbers was calculated by retinal Nissl staining.Morphology of retina in frozen section was examined under the light microscope.The experiment followed the Standard of Association for Research in Vision and Ophthalmology. Results The IOP was elevated in model eyes from 1 day through 3 weeks after operation with statistically different in comparison with before operation(P<0.05).No obvious differences in IOP changg was found hetween the triptolide group and the normal saline group at each time point(P>0.05).The numbers of RGCs of model eyes in normal saline group decreased gradually after operation,but no evident decline of numbers of RGCs in model eyes in triptolide group. RGCs in triptolide group were considerably more than those of normal saline group in various time points after operation ( P<0. 05). However,no obvious difference in RGCs numbers was found between model eyes and control eyes in Triptolide group. Conclusion Triptolide could protect RGCs in glaucomatous eyes,and its effect does not depend on IOP in chronic glaucoma model.

Triptolide Protects Astrocytes from Hypoxia/Reoxygenation Injury

[Tripotolide Ameliorates Inflammation and Apoptosis Induced by Focal Cerebral Ischemia/reperfusion in Rats].

Anti-inflammatory and neuroprotective effects of Triptolide via the NF-κB signaling pathway in a rat MCAO model.

[Triptolide reduces neuronal damage in cerebral ischemia-reperfusion rats by promoting microglial M2 polarization]

Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice

Triptolide Protects Podocytes from Injury

Triptolide Inhibits TNF-α, IL-1β and NO Production in Primary Microglial Cultures

CX3CR1 mediates the neuroprotective effect of triptolide on 1-methyl-4-phenylpyridinium-induced hemiparkinson rats

Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation.

Triptolide Protects Podocytes from TGF-β-induced Injury by Preventing Mir-30 Downregulation.

Triptolide Promotes the Repair of Spinal Cord Injury by Inhibiting Autophagy in Rats Models

Autophagy Upregulation and Apoptosis Downregulation in DAHP and Triptolide Treated Cerebral Ischemia.

Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage.

Trichostatin A Enhances OGD-astrocyte Viability by Inhibiting Inflammatory Reaction Mediated by NF-κB

Triptolide improves spinal cord injury by promoting autophagy and inhibiting apoptosis

Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice.

Triptolide’s anti-inflammatory effects on ARDS by down-regulating miR-9-5p and up-regulating LRG1 and CLDN5

Triptolide Ameliorates Podocyte Injury Induced by the Terminal Complement Factor C5b-9 in Vitro

Triptolide Protects Against 1-Methyl-4-phenyl Pyridinium-Induced Dopaminergic Neurotoxicity in Rats: Implication for Immunosuppressive Therapy in Parkinson’s Disease

Neuroprotective effect of triptolide on neuronal inflammation in rats with mild brain injury

Protective effect of triptolide on retinal ganglion cells in chronic ocular hypertension model